Novan Announces Favorable Preclinical Safety Data and Intent to Advance SB019 for Treatment of COVID-19

NEXT STORY
Iovance Biotherapeutics Announces Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Cell Therapy in Multiple Solid Tumors at Society for Immunotherapy of Cancer (SITC) Annual Meeting
PREV STORY
SCYNEXIS Announces Successful Completion of Phase 1 Trial Evaluating Intravenous (IV) Formulation of Ibrexafungerp
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche response to COVID-19 pandemic

author_avatar
NASDAQ Market News

VBL Therapeutics to Report Second Quarter 2018 Financial Results on August 16

TEL AVIV, Israel, Aug. 01, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage ...

author_avatar
NASDAQ Market News

Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B Data Accepted for Oral and Poster Presentations at EASL 2021

author_avatar
NASDAQ Market News